Member Login
  1. Stocks
    2. /
  2. Shield Therapeutics plc (LSE: STX)
    3. /

LSE:STX (Shield Therapeutics plc)

About STX

Shield Therapeutics PLC is a specialty pharmaceutical company focused on the development and commercialization of late stage, hospital-focused pharmaceuticals which address areas of high unmet medical need. The company's operating segments which is based on key products include Feraccru, used as a novel oral treatment for iron deficiency anemia in patients, which is commercially available and PT20 used in treating hyperphosphatemia, which is in its last stage of completion. It generates maximum revenue from Feraccru segment.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Shield Therapeutics plc (LSE: STX) Latest News

Engineer Project Manager Talks With Scientist working on Computer
Investing Articles

At 6.6p, could this fast-growing penny stock be a millionaire-maker?

| Mark Hartley

Mark Hartley is impressed by the growth trajectory and product pipeline of an upcoming pharma penny stock. But is it…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

2 growth stocks I’d never heard of — until they soared nearly 40% this week!

| Mark Hartley

Two little-known FTSE shares, Shield Therapeutics and Pantheon Resources, soared up to 40% this week. Could these growth stocks keep…

Read more »

Businessman hand flipping wooden block cube from 2024 to 2025 on coins
Investing Articles

This 5p penny stock is crushing the stock market in 2025

| Mark Hartley

This micro-cap share is outperforming global stock markets by tenfold this year! Mark Hartley investigates the company's prospects.

Read more »

Investing Articles

Should I buy these 2 penny stocks?

| Royston Wild

News coming out of these low-cost UK shares has been encouraging in recent months. Is now the time for me…

Read more »

Investing Articles

Here are two UK small-cap stocks I’d buy right now

| James J. McCombie

Uk small-cap stocks can offer great returns but are often very risky. I think these two shares are worth a…

Read more »

Investing Articles

Why I’d ditch this high-risk growth share to buy British American Tobacco plc

| Roland Head

After a sharp decline, British American Tobacco plc (LON:BATS) could be worth a fresh look.

Read more »

Investing Articles

Is Shield Therapeutics plc a better bet than AstraZeneca plc?

| Alan Oscroft

Does the small-cap potential of Shield Therapeutics plc (LON: STX) beat the blue chip reliability of AstraZeneca plc (LON: AZN)…

Read more »